Jump to navigation
This post was originally published by the Dengue Vaccine Initiative (DVI).
The 9th International Rotavirus Symposium brought together 365 participants from 65 countries from August 2-3, 2010 in Johannesburg, South Africa.
By Stephanie Bricking, Albert B. Sabin Archivist, University of Cincinnati
In partnership with the Fraunhofer Center for Molecular Biotechnology and the Walter Reid Army Institute for Research, the Sabin Vaccine Institute has successfully expressed the hookworm-derived antigen Na-APR-1.
A new study asserts that a particular type of schistosomiasis may predispose women to contracting HIV.